Cargando…
A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
BACKGROUND: Higher skin pH in atopic dermatitis contributes to impaired epidermal barrier. A moisturizer compatible with physiological pH could improve atopic dermatitis. OBJECTIVE: To determine the effect of a physiologically compatible pH moisturizer in atopic dermatitis. METHODS: A randomized hal...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253898/ https://www.ncbi.nlm.nih.gov/pubmed/32291095 http://dx.doi.org/10.1016/j.abd.2019.11.007 |
_version_ | 1783539419515453440 |
---|---|
author | Goh, Siew Wen Jamil, Adawiyah Safian, Nazarudin Md Nor, Norazirah Muhammad, Norliza Saharudin, Nur Liyana |
author_facet | Goh, Siew Wen Jamil, Adawiyah Safian, Nazarudin Md Nor, Norazirah Muhammad, Norliza Saharudin, Nur Liyana |
author_sort | Goh, Siew Wen |
collection | PubMed |
description | BACKGROUND: Higher skin pH in atopic dermatitis contributes to impaired epidermal barrier. A moisturizer compatible with physiological pH could improve atopic dermatitis. OBJECTIVE: To determine the effect of a physiologically compatible pH moisturizer in atopic dermatitis. METHODS: A randomized half body, double blind, controlled trial involving patients with stable atopic dermatitis was performed. pH-modified moisturizer and standard moisturizer were applied to half body for 6 weeks. RESULTS: A total of 6 (16.7%) males and 30 (83.3%) females participated. Skin pH reductions from week 0, week 2 and 6 were significant at the forearms (5.315 [0.98] to 4.85 [0.54] to 5.04 [0.78], p = 0.02) and abdomen (5.25 [1.01], 4.82 [0.64], 5.01 [0.59], p = 0.00) but not at the shins (5.01 [0.80], 4.76 [0.49], 4.85 [0.79], p = 0.09) with pH-modified moisturizer. Transepidermal water loss (TEWL) at the forearms decreased (4.60 [2.55] to 3.70 [3.10] to 3.00 [3.55], p = 0.00), abdomen (3.90 [2.90] to 2.40 [3.45] to 2.70 [2.25], p = 0.046). SCORAD improved from 14.1 ± 12.75 to 10.5 ± 13.25 to 7 ± 12.25, p = 0.00. In standard moisturizer group, pH reductions were significant at the forearms (5.29 [0.94] to 4.84 [0.55] to 5.02 [0.70], p = 0.00) and abdomen (5.25 [1.09], 4.91 [0.63], 5.12 [0.66], p = 0.00). TEWL at the forearm were (4.80 [2.95], 4.10 [2.15], 4.60 [3.40], p = 0.67), shins (3.80 [1.40], 3.50 [2.35], 4.00 [2.50], p = 0.91) and abdomen (3.70 [2.45], 4.10 [3.60], 3.40 [2.95], p = 0.80). SCORAD improved from 14.2 ± 9.1 to 10.9 ± 10.65 to 10.5 ± 11, p = 0.00. Reduction in pH was observed with both moisturizers while TEWL significantly improved with pH-modified moisturizer. pH-modified moisturizer resulted in greater pH, TEWL and SCORAD improvements however the differences were not significant from standard moisturizer. STUDY LIMITATION: Skin hydration was not evaluated. CONCLUSION: Moisturization is beneficial for atopic dermatitis; use of physiologically compatible pH moisturizer is promising. |
format | Online Article Text |
id | pubmed-7253898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Sociedade Brasileira de Dermatologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-72538982020-06-01 A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() Goh, Siew Wen Jamil, Adawiyah Safian, Nazarudin Md Nor, Norazirah Muhammad, Norliza Saharudin, Nur Liyana An Bras Dermatol Investigation BACKGROUND: Higher skin pH in atopic dermatitis contributes to impaired epidermal barrier. A moisturizer compatible with physiological pH could improve atopic dermatitis. OBJECTIVE: To determine the effect of a physiologically compatible pH moisturizer in atopic dermatitis. METHODS: A randomized half body, double blind, controlled trial involving patients with stable atopic dermatitis was performed. pH-modified moisturizer and standard moisturizer were applied to half body for 6 weeks. RESULTS: A total of 6 (16.7%) males and 30 (83.3%) females participated. Skin pH reductions from week 0, week 2 and 6 were significant at the forearms (5.315 [0.98] to 4.85 [0.54] to 5.04 [0.78], p = 0.02) and abdomen (5.25 [1.01], 4.82 [0.64], 5.01 [0.59], p = 0.00) but not at the shins (5.01 [0.80], 4.76 [0.49], 4.85 [0.79], p = 0.09) with pH-modified moisturizer. Transepidermal water loss (TEWL) at the forearms decreased (4.60 [2.55] to 3.70 [3.10] to 3.00 [3.55], p = 0.00), abdomen (3.90 [2.90] to 2.40 [3.45] to 2.70 [2.25], p = 0.046). SCORAD improved from 14.1 ± 12.75 to 10.5 ± 13.25 to 7 ± 12.25, p = 0.00. In standard moisturizer group, pH reductions were significant at the forearms (5.29 [0.94] to 4.84 [0.55] to 5.02 [0.70], p = 0.00) and abdomen (5.25 [1.09], 4.91 [0.63], 5.12 [0.66], p = 0.00). TEWL at the forearm were (4.80 [2.95], 4.10 [2.15], 4.60 [3.40], p = 0.67), shins (3.80 [1.40], 3.50 [2.35], 4.00 [2.50], p = 0.91) and abdomen (3.70 [2.45], 4.10 [3.60], 3.40 [2.95], p = 0.80). SCORAD improved from 14.2 ± 9.1 to 10.9 ± 10.65 to 10.5 ± 11, p = 0.00. Reduction in pH was observed with both moisturizers while TEWL significantly improved with pH-modified moisturizer. pH-modified moisturizer resulted in greater pH, TEWL and SCORAD improvements however the differences were not significant from standard moisturizer. STUDY LIMITATION: Skin hydration was not evaluated. CONCLUSION: Moisturization is beneficial for atopic dermatitis; use of physiologically compatible pH moisturizer is promising. Sociedade Brasileira de Dermatologia 2020 2020-03-21 /pmc/articles/PMC7253898/ /pubmed/32291095 http://dx.doi.org/10.1016/j.abd.2019.11.007 Text en © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Investigation Goh, Siew Wen Jamil, Adawiyah Safian, Nazarudin Md Nor, Norazirah Muhammad, Norliza Saharudin, Nur Liyana A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() |
title | A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() |
title_full | A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() |
title_fullStr | A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() |
title_full_unstemmed | A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() |
title_short | A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() |
title_sort | randomized half-body, double blind, controlled trial on the effects of a ph-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() |
topic | Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253898/ https://www.ncbi.nlm.nih.gov/pubmed/32291095 http://dx.doi.org/10.1016/j.abd.2019.11.007 |
work_keys_str_mv | AT gohsiewwen arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT jamiladawiyah arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT safiannazarudin arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT mdnornorazirah arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT muhammadnorliza arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT saharudinnurliyana arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT gohsiewwen randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT jamiladawiyah randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT safiannazarudin randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT mdnornorazirah randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT muhammadnorliza randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis AT saharudinnurliyana randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis |